Job Description

###

Key Information

Salary

: Commencement on the salary range is subject to comparable skills and experience.

Reporting to: Professor Axel Behrens

Accountable to: Dr Patrick Kierkegaard

Duration of Contract

: Fixed Term for 2 years (with possibility of extension)

Hours per week

:

35 hours per week (Full Time)

Location

: Chelsea

Closing Date

:

16th September 2025

This role is eligible for ICR Sponsorship. Support will be provided for costs associated with Visa application. If you are considering relocating to the UK, further information can be found here.
###

Job Details

Under the guidance of Cancer Technology Catalyst team lead Dr Patrick Kierkegaard, we are seeking to recruit a Health Economist to pioneer evaluations at the CRUK Convergence Science Centre. Based in South Kensington, London, with travel to partner sites (The Royal Marsden NHS Foundation Trust, ICR Sutton, Imperial College Healthcare NHS Trust). The successful candidate will lead early-stage health economic modelling and health technology assessment (HTA) for cutting-edge oncology innovations, including precision drugs, diagnostics, treatments, clinical guidelines, and digital health technologies (DHTs).

Department/Directorate Information

The Cancer Research UK Convergence Science Centre (CSC) is a partnership between Imperial College London and The Institute of Cancer Research (ICR) with funding from Cancer Research UK. Convergence research is driven by a societal need and utilises a deep integration across disciplines. Professor Axel Behrens is the Scientific Director of the CRUK Convergence Science Centre.

This position of Health Economist is integrated within our Cancer Technology Catalyst team (CTC). The CTC is an initiative designed to expedite the journey of promising cancer technologies from concept to clinical impact. Led by a diverse team of experts, the CTC is committed to unlocking the full potential of innovative solutions and addressing the challenges inherent in bringing them to patients. By harnessing a collaborative Team Science approach, the CTC works closely with Principal Investigators and their teams to develop comprehensive evidence packages that not only inform robust value propositions for cancer technologies, but also strategically position them for successful clinical integration.

About you

Please see the attached job description for essential skills and qualifications for this role, and further information.

What we offer

A dynamic and supportive research environment Access to state-of-the-art facilities and professional development opportunities Collaboration with leading researchers in the field Competitive salary and pension

We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Patrick Kierkegaard via p.kierkegaard@imperial.ac.uk.

###

About The Institute of Cancer Research

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.



The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.



The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.

At the Institute of Cancer Research, we champion diversity as we believe it fuels innovation and drives impactful research. We welcome applicants from all walks of life, valuing diverse perspectives that enrich our work.

Don't let a checklist of qualifications hold you back - if you're passionate about the role, we want to hear from you. Your unique experiences and backgrounds contribute to the richness of our team. We are committed to being an equal opportunity for all, regardless of ethnicity, gender, age, sexual orientation, disability, or any other dimension of diversity. Join us in creating an inclusive environment where everyone's voice is heard and valued.